Skip to main content

Table 5 Associations between retention in care measures and CD4 cell count (< 500 cells/µL) in PLWH + T2DM by age groups

From: Retention in care in aging adults with a dual diagnosis of HIV infection and type 2 diabetes mellitus: a longitudinal retrospective cross-sectional study

Age group

Variablesa

B

SE

Wald

df

Sig.

Exp(B)

95% CI

Lower

Upper

OALWH + T2DM (n = 105)

Missed visits (count)

2.423

1.03

5.537

1

0.019*

11.277

1.499

84.843

Missed visits (dichotomous)

2.069

1.716

1.454

1

0.228

7.918

0.274

228.713

Visit adherence

5.582

5.733

0.948

1

0.33

265.714

0.004

20153270.43

4-month visit constancy

0.685

0.566

1.464

1

0.226

1.983

0.654

6.014

6-month gap

0.407

0.864

0.222

1

0.638

1.502

0.276

8.173

HRSA HAB measure (retained)

0.082

0.618

0.018

1

0.894

1.086

0.323

3.648

Constant

− 9.479

5.378

3.107

1

0.078

0

  

Total Chi square (6) = 10.421, p > 0.05

Hosmer–Lemeshow Chi square (3) = 0.89, p > 0.05

YALWH + T2DM (n = 34)

Missed visits (count)

10.804

16,337.328

0

1

0.999

49,219.776

0

 

Missed visits (dichotomous)

30.158

62,616.205

0

1

1

1.25186E + 13

0

 

Visit adherence

4.645

235,894.115

0

1

1

104.095

0

 

4-month visit constancy

0.185

1.645

0.013

1

0.911

1.203

0.048

30.251

HRSA HAB measure (retained)

− 0.849

1.465

0.336

1

0.562

0.428

0.024

7.56

Constant

− 35.14

180,003.341

0

1

1

0

  

Chi square (6) = 7.07, p > 0.05

Hosmer–Lemeshow Chi square (4) = 2.29, p > 0.05

  1. HRSA HAB measure the US Health Resources and Services Administration HIV/AIDS Bureau (HRSA HAB) measure, PLWH + T2DM persons living with HIV and diabetes, all ages, OALWH + T2DM older adults with HIV and T2DM, YALWH + T2DM younger adults with HIV and T2DM
  2. * p < 0.05
  3. aStep 1a. variables: missed visits (count), missed visits (dichotomous), visit adherence, 4-month visit constancy, 6-month gap, HRSA HAB measure; Step 1b. variables: missed visits (dichotomous), visit adherence, 4-month visit constancy, HRSA HAB measure